Allarity Therapeutics (ALLR) Cash & Equivalents (2020 - 2026)
Allarity Therapeutics (ALLR) reported Cash & Equivalents of $16.98 million for Q2 2026, down 4.6% from $17.8 million a year earlier and down 14.3% from the prior quarter.
Allarity Therapeutics (ALLR) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Allarity Therapeutics posted Cash & Equivalents of $14.69 million, down 24.8% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 118.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $19.53 million in FY2024, $166,000 in FY2023 (-91.8%), $2.03 million in FY2022 (-89.6%) and $19.56 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $166,000 in Q4 2023 and a high of $25.2 million in Q1 2025.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with an average decline of 14.6% over the last four quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2022 (growth of 16.4%); the low point was Q1 2023 (a decline of 98.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $19.81 million (Q1 2026), $14.69 million (Q4 2025) and $16.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Allarity Therapeutics | 1.67 Mn | 1.67 Mn | - | 16.98 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.98 Mn |
| Mar 31, 2026 | 19.81 Mn |
| Dec 31, 2025 | 14.69 Mn |
| Sep 30, 2025 | 16.90 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 25.20 Mn |
| Dec 31, 2024 | 19.53 Mn |
| Jun 30, 2024 | 19.23 Mn |
| Mar 31, 2024 | 312,000.00 |
| Dec 31, 2023 | 166,000.00 |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 420,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 7.68 Mn |
| Mar 31, 2022 | 14.54 Mn |
| Dec 31, 2021 | 19.56 Mn |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 6.60 Mn |
Allarity Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALLR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ALLR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALLR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();